Summary
Optimum antimicrobial therapy effective against anaerobes is required to rapidly resolve infections due to these organisms and to prevent serious complications. Selection of antimicrobial therapy should be based on clinical experience and presumptive evidence until culture and sensitivity tests are available. If an abscess should develop, surgical drainage (when possible) is of paramount importance.
Antimicrobial therapy for anaerobic infections should usually be given for prolonged periods because of the tendency for relapse, and should include coverage for aerobic bacteria whenever they are present. Penicillin G remains the drug of choice for most anaerobic infections except those caused by β-lactamase-producing Bacteroides spp. such as B. fragilis and B. melaninogenicus, and some strains of Fusobacterium varium, which can be resistant. Other antimicrobials which are available for treatment of anaerobic infections in paediatric patients, and are generally active against B. fragilis, are carbenicillin, ticarcillin, chloramphenicol, clindamycin and cefoxitin. Experience in the use of metronidazole suggests that it could be a very valuable antimicrobial agent in the treatment of anaerobic infections.
Experience with synergistic antimicrobial combinations in the treatment of anaerobic infections is limited; only experimental data are available suggesting synergism between penicillin and aminoglycosides against some Bacteroides spp. β-Lactamase-producing anaerobic bacteria may protect other penicillin-susceptible bacteria in mixed infections. This phenomenon may explain penicillin failure in eradicating mixed infections.
Similar content being viewed by others
References
Beard, CM.; Noller, K.L.; O’Fallon, M.; Kurland, L.T. and Dockcrty, M.B.: Lack of evidence for cancer due to use of metronidazole. New England Journal of Medicine 301: 519–522 (1979).
Berlatzky, Y.; Rubin, S.Z.; Michel, J.; Sacks, T. and Schiller, M.: Use of clindamycin and gentamicin in pediatric colonie surgery. Journal of Pediatric Surgery 11: 943–946 (1976).
Berman, B.W.; King, F.H. Jr., Rubenstein, D.S. and Long, S.S.: Bactcroides fragilis meningitis in a neonate successfully treated with metronidazole. Journal of Pediatrics 93: 793–795 (1979).
Brook, I.: Carbenicillin in treatment of aspiration pneumonia in children. Current Therapeutic Research 23: 136–147 (1978).
Brook, I.: Clindamycin in treatment of aspiration pneumonia in children. Antimicrobial Agents and Chemotherapy 15: 342–345 (1979a).
Brook, I.: Bacteriology and treatment of chronic otitis media in children. Laryngoscope 89: 1129–1134 (1979b).
Brook, I.: Anaerobic isolates in chronic recurrent supperative otitis medical treatment with carbenicillin alone and in combination with gentamicin. Infection 5: 247–251 (1979c).
Brook, I.; Calhoun, L. and Yocum, P.: Beta-lactamase-producing isolates of Bacteroides species from children. Antimicrobial Agents and Chemotherapy 18: 164–166 (1980).
Brook, I.: In vitro activity of moxalactam (LY-P27935) against anaerobic microorganisms. Journal of Antimicrobial Chemotherapy 6: 676–679 (1980).
Brook, I.; Gillmore, J.; Coolbaugh, J.C. and Walker, R.I.: In vitro protection of group A beta hemolytic streptococci by Bacteroides. Journal of Antimicrobial Chemotherapy (In press 1983).
Brook, I.: Bacteriology of intracranial abscess in children. Journal of Neurosurgery 54: 484–488 (1981).
Brook, I.: Treatment of anaerobic infections in children with metronidazole. Developmental Pharmacology and Therapeutics 6: 187–198 (1983).
Brook, I.; Coolbaugh, J.C. and Walker, R.I.: In vitro and in vivo synergism between aminoglycoside and penicillin against the Bacteroides melaninogenicus group. Abstract no. 653. Proceedings of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Florida 1982.
Bryan, L.E.; Kowand, S.K. and Van Den Elzen, H.M.: Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 15: 7–13 (1979).
Bryant, R.E.; Rashad, A.L.; Mazza, J.A. and Hammond, D.: β-Lactamasc activity in human pus. Journal of Infectious Diseases 142: 594–601 (1980).
Busch, D.F.; Jureshi, L.A.; Sutter, V.L. and Finegold, S.M.: Susceptibility of respiratory tract anaerobes to orally administered penicillins and cephalosporins. Antimicrobial Agents and Chemotherapy 10: 713–720 (1976).
Busch, D.F.; Sutter, V.L. and Finegold, S.M.: Activity of combinations of antimicrobial agents against Bacteroides fragilis. Journal of Infectious Diseases 133: 321–328 (1976).
Chow, A.W.; Montgomerie, J.Z. and Guze, L.B.: Parenteral clindamycin therapy for severe anaerobic infections. Archives of Internal Medicine 134: 78–82 (1974).
Chow, A.W.; Patten, V. and Guze, L.B.: Susceptibility of anaerobic bacteria to metronidazole: Relative resistance of non-spore forming gram-positive bacilli. Journal of Infectious Diseases 131: 182–185 (1975).
Cohen, S.M.; Entruk, E.; Von Esch, A.M.; Crovetti, A.J. and Bryan, G.T.: Carcinogenicity of 5-nitrofurans 5-nitromidazoles, 4-nitrobenzenes and related compounds. Journal of the National Cancer Institute 51: 403–417 (1973).
de Louvois, J. and Hurley, R.: Inactivation of penicillin by purulent exudates. British Medical Journal 1: 998–1000 (1977).
Fass, R.J.; Rotilie, C.A. and Prior, R.B.: Interaction of clindamycin and gentamicin in vitro. Antimicrobial Agents and Chemotherapy 6: 582–587 (1974).
Finegold, S.M.; Harada, N.E. and Miller, L.G.: Lincomycin activity against anaerobes and effect on normal human fecal flora. Antimicrobial Agents and Chemotherapy 6: 659–667 (1966).
Finegold, S.M.; Bartlett, J.G.; Chow, A.W.; Flora, D.J.; Grogach, S.L.; Harder, E.J. and Tally, F.P.: Management of anaerobic infections. Annals of Internal Medicine 83: 375–389 (1975).
Fiedelman, W. and Webb, CD.: Clinical evaluation of carbenicillin in the treatment of infection due to anaerobic bacteria. Current Therapeutic Research 18: 441–451 (1975).
Finegold, S.M.: Anaerobic Bacteria in Human Disease (Academic Press, New York 1977).
George, W.L.; Sutter, V.L.; Goldstein, E.J.C.; Ludsig, S.L. and Finegold, S.M.: Aetiology of antimicrobial agent-associated colitis. Lancet 1: 802 (1978).
Gorbach, S.L. and Bartlett, J.G.: Anaerobic infections. New England Journal of Medicine 290: 1177–1184, 1237–1245, 1289–1294 (1974).
Gorbach, S.L. and Thadepalli, H.: Clindamycin in the treatment of pure and mixed anaerobic infections. Archives of Internal Medicine 134: 87–92 (1974).
Hackman, A.S. and Wilkins, T.D.: In vivo protection of Fusobactcrium necrophorum from penicillin by Bacteroides fragilis. Antimicrobial Agents and Chemotherapy 7: 698–703 (1975).
Hackman, A. and Wilkins, T.D.: Influence of penicillinase production by strains of Bacteroides melaninogenicus and Bacteroides oralis on penicillin therapy of an experimental mixed anaerobic infection in mice. Archives of Oral Biology 21: 385–389 (1976).
Hescltine, P.N.R.; Busch, D.F.; Meyer, R.D. and Finegold, S.M.: Cefoxitin: Clinical evaluation in 38 patients. Antimicrobial Agents and Chemotherapy 11: 427–434 (1977).
Ingham, H.R.; Selkon, J.B. and Roxby, CM.: Bacteriological study of otogenic cerebral abscesses: Chemotherapeutic role of metronidazole. British Medical Journal 2: 991–994 (1977).
Kagnoff, M.F.; Armstrong, D. and Blevins, A.: Bacteroides bacteremia. Experience in a hospital for neoplastic disease. Cancer 29: 245–251 (1972).
Laufer, J.; Mignon, H. and Videau, D.: L’association metronidazole-spiramycine: Concentrations et syntergie in situ comparecs aux CMI de la flore buccale. Revue de Stomatologie et de Chirurgie Maxillofaciale 74: 387–392 (1974).
Law, B.J. and Marks, M.I.: Excellent outcome of Bacteroides meningitis in a newborn treated with metronidazole. Pediatrics 66: 463–465 (1980).
Leigh, D.A.: Bacteroides infections. Lancet 2: 1081–1082 (1973).
Lewis, P.; Goldstein, J.C.; Sutter, L. and Finegold, S.M.: Erythromycin therapy of anaerobic infections; in Current Chemotherapy, pp. 653–655 (American Society for Microbiology, Washington, DC 1978).
Masuda, G. and Tomioka, S.: Possible beta-lactamase activities detectable in infective clinical specimens. Journal of Antibiotics (Tokyo) 30: 1093–1097 (1977).
O’Grady, L.R. and Ralph, E.D.: Anaerobic meningitis and bacteremia caused by Fusobacterium species. American Journal of Diseases of Children 130: 871–873 (1976).
O’Keefe, J.P.; Tally, F.P.; Barza, M. and Gorbach, S.L.: Inactivation of penicillin G during experimental infection with Bacteroides fragilis. Journal of Infectious Diseases 137: 437–442 (1978).
Pinkus, G.; Veto, G. and Braude, A.: Bacteroides pcnicillinase. Journal of Bacteriology 96: 1437–1438 (1968).
Rahal, J.J.: Antibiotic combinations: The clinical relevance of synergy and antagonism. Medicine 57: 179–195 (1978).
Ralph, E.D. and Kirby, W.M.: Unique bacteriocidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Antimicrobial Agents and Chemotherapy 8: 409–414 (1975).
Randolph, M.F. and Morris, K.E.: Clindamycin associated colitis in children. A prospective study and a negative report. Clinical Pediatrics 26: 722–725 (1977).
Reading, C. and Cole, M.: Clavulanic acid: A beta-lactamase inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrobial Agents and Chemotherapy 11: 852–857 (1977).
Rodriguez, W.; Ross, S.; Khan, W.; McKay, D. and Moskowitz, P.: Clindamycin in treatment of osteomyelitis in children. A report of 29 cases. American Journal of Diseases of Children 131: 1088–1093 (1977).
Rom, S.; Flynn, D. and Noone, P.: Anaerobic infections in a neonate. Early detection by gas liquid chromatography and response to metronidazole. Archives of Disease in Childhood 52: 740 (1977).
Roy, I.; Bach, V. and Thadepalli, A.: In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin. Antimicrobial Agents and Chemotherapy 11: 258–261 (1977).
Rustia, M. and Shubik, P.: Experimental induction of hempatomas mammary tumors and other tumors with metronidazole in noninbred Sas: WRC (WT)BR rats. Journal of the National Cancer Institute 63: 863–867 (1979).
Shoemaker, E.H. and Yow, E.M.: Clinical evaluation of erythromycin. Archives of Internal Medicine 93: 397–406 (1954).
Sutter, V.L. and Finegold, S.M.: Susceptibility of anaerobic bacteria to carbenicillin, cefoxitin, and related drugs. Journal of Infectious Diseases 131: 417–422 (1975).
Sutter, V.L. and Finegold, S.M.: Susceptibility of anaerobic bacteria to 23 antimicrobial agents. Antimicrobial Agents and Chemotherapy 10: 736–752 (1976).
Tacking, R.: Pencillinase producing bacteria in mixed infections in rabbits treated with penicillin. Acta Pathologica et Microbiologica Scandinavica 35: 445–454 (1954).
Tally, F.P.; Jacobus, N.V.; Bartlett, J.G. and Gorbach, S.L.: In vitro activity of penicillins against anaerobes. Antimicrobial Agents and Chemotherapy 7: 413–414 (1975).
Tally, P.; Sutter, L. and Finegold, S.M.: Treatment of anaerobic infections with metronidazole. Antimicrobial Agents and Chemotherapy 7: 672–675 (1975).
Tally, F.P.: Factors affecting antimicrobial agents in an anaerobic abscess. Journal of Antimicrobial Chemotherapy 4: 299–302 (1978).
Tedesco, F.J.; Barton, R.W. and Alpers, D.H.: Clindamycin associated colitis: A prospective study. Annals of Internal Medicine 81: 429 (1974).
Thadepalli, H. and Huang, J.T.: Treatment of anaerobic infections: Carbenicillin alone compared with clindamycin and gentamicin. Current Therapeutic Research 22: 549–555 (1977).
Whelan, J.P.F. and Hale, J.H.: Bactericidal activity of metronidazole against Bacteroides fragilis. Journal of Clinical Pathology 26: 393–395 (1973).
Wust, J. and Wilkins, T.D.: Effect of clavulanic acid on anaerobic bacteria resistant to beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy 13: 130–133 (1978).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brook, I. Antimicrobial Drugs Used in the Management of Anaerobic Infections in Children. Drugs 26, 520–529 (1983). https://doi.org/10.2165/00003495-198326060-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198326060-00004